Furthermore, anti-TNF-α and anti-IL1-R treatment also reduced tumor growth, suggesting indirect effects of inflammation as a determinant of tumor burden in driving atrophy (Gelin et al., 1991). This evidence concerns the gene IL1R1 and neoplasm.